Regular inhaled salbutamol and asthma control: the TRUST randomised trial
Authors:
- Sarah M DennisSDSarah M Dennis
- Stephen J SharpSSStephen J Sharp
- Madge R VickersMVMadge R Vickers
- Chris D FrostCFChris D Frost
- Graham K CromptonGCGraham K Crompton
- Peter J BarnesPeter J Barnes
- Tak H LeeTLTak H Lee
- 1 May 2000
- journal article
- Published by Elsevier in The Lancet
- Vol. 355 (9216) , 1675-1679
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- The British Guidelines on Asthma Management * 1995 Review and Position StatementThorax, 1997
- The ??2-Agonist ControversyDrug Safety, 1994
- A Cohort Analysis Of Excess Mortality In Asthma And The Use Of Inhaled Beta-AgonistsAmerican Journal of Respiratory and Critical Care Medicine, 1994
- Regular inhaled beta agonist in asthma: effects on exacerbations and lung function.Thorax, 1993
- The Use of β-Agonists and the Risk of Death and near Death from AsthmaNew England Journal of Medicine, 1992
- Regular inhaled beta-agonist treatment in bronchial asthmaThe Lancet, 1990
- Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81.Thorax, 1990
- PRESCRIBED FENOTEROL AND DEATH FROM ASTHMA IN NEW ZEALAND, 1981-83; CASE-CONTROL STUDYThe Lancet, 1989
- REBOUND INCREASE IN BRONCHIAL RESPONSIVENESS AFTER TREATMENT WITH INHALED TERBUTALINEThe Lancet, 1988
- Observations on recent increase in mortality from asthma.BMJ, 1968